Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...

The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply ...

GLP-1 agonist drugs like Ozempic, and SLGT2 inhibitor drugs like Jardiance have been linked with a lower risk of a second ...

Jim Gaffigan has a sleek new look to match his recent Hollywood renaissance, which includes his hilarious turn on SNL as vice ...

A new study supports the notion that the same mechanisms that help folks lose weight with Ozempic and its kin also work to ...

GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with ...

The former "Beverly Hills, 90210" star said she's not ashamed to have used the diabetes drug Mounjaro to lose weight after her fifth child.

Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...

Four out of five men and women in the United States will be overweight or obese by 2050 if current trends hold, a new study ...

There have been a slew of studies recently supporting the notion that the same mechanisms that help folks lose weight ...

A new study has shed light on the health risks faced by people who stop using weight-loss medications Ozempic or Wegovy.